Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Goodwill (2019 - 2025)

Silence Therapeutics' Goodwill history spans 7 years, with the latest figure at $10.6 million for Q4 2025.

  • For Q4 2025, Goodwill rose 13.09% year-over-year to $10.6 million; the TTM value through Dec 2025 reached $10.6 million, up 13.09%, while the annual FY2025 figure was $10.6 million, 13.09% up from the prior year.
  • Goodwill for Q4 2025 was $10.6 million at Silence Therapeutics, roughly flat from $10.6 million in the prior quarter.
  • Across five years, Goodwill topped out at $10.6 million in Q4 2025 and bottomed at $9.4 million in Q3 2024.
  • The 5-year median for Goodwill is $9.8 million (2024), against an average of $10.0 million.
  • The largest annual shift saw Goodwill decreased 8.21% in 2022 before it increased 13.09% in 2025.
  • A 5-year view of Goodwill shows it stood at $10.2 million in 2021, then fell by 8.21% to $9.4 million in 2022, then rose by 3.58% to $9.7 million in 2023, then dropped by 3.48% to $9.4 million in 2024, then grew by 13.09% to $10.6 million in 2025.
  • Per Business Quant, the three most recent readings for SLN's Goodwill are $10.6 million (Q4 2025), $10.6 million (Q3 2025), and $10.6 million (Q2 2025).